Target intelligence / Profile preview

Marine luciferase

Molecular classification
Enzyme, Oxidoreductase, Reporter protein (biotechnology context)
01

Overview

Marine luciferase refers to a class of enzymes found in various marine organisms—such as copepods, shrimp, sea pansies (Renilla), and others—that catalyze the oxidation of light-emitting substrates (primarily coelenterazine) to produce bioluminescence[7][3][9][4]. These enzymes are not structurally conserved across all marine species; for instance, copepod luciferases are small, secreted proteins distinguished by their strong, stable blue light emission and minimal cofactor requirement (they do not require ATP, just oxygen and substrate)[7][3][9]. Marine luciferases have evolved multiple times in different lineages and typically show little sequence similarity to each other or to terrestrial luciferases (like firefly luciferase)[7][5][8]. Their principal biological roles in nature include predator evasion, prey attraction, and species communication through light emission[3][4]. In biotechnology, marine luciferases (notably Gaussia and Renilla luciferase) are extensively used as assay reporters due to their secreted nature, high sensitivity, and compatibility with live-cell or extracellular monitoring[7][9]. Marine luciferases are not considered therapeutic targets and are not associated with human pathologies; thus, there are no drugs designed to target them, but their substrates (like coelenterazine) are used in research. Overall, "marine luciferase" is a broad, functionally defined, but structurally diverse enzyme class, not a single standardized molecular entity.

Other names
marine luciferasescoelenterazine-dependent luciferasessecreted luciferasescopepod luciferaseRenilla luciferaseGaussia luciferaseMetridia luciferaseOplophorus luciferase
02

Mechanism of action

Catalyze the oxidation of luciferin substrate (e.g., coelenterazine) to produce visible light

03

Biological functions

Oxidation of luciferin substrates to produce bioluminescenceDefense response (in marine organisms)Communication (in marine organisms)Reporter assay tool (biotechnology)
04

Disease associations

Other (no direct role in diseases; primarily used as research and diagnostic tools)
05

Safety considerations

Immunogenicity in therapeutic uses (theoretical)Substrate or reaction byproduct toxicity (rare, mainly in experimental animal studies)

Beyond the preview

Go deeper on Marine luciferase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marine luciferase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call